Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Targeting NLRP3 inflammasome pathway prevents C. septicum-induced lethality

June 8, 2022

Novel fungal Hsp90 inhibitors for the treatment of azole-resistant candidiasis

June 7, 2022

Molecule "superglues" itself to enzyme to fight all stages of malaria parasite

June 7, 2022

MARCH8 attenuates cGAS-mediated innate autoimmune responses

June 3, 2022

Expanded collaboration research on COVID-19 protease inhibitors

June 2, 2022

Olverembatinib, ponatinib identified as possible treatments for COVID-related cytokine storm

June 1, 2022

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

May 31, 2022

Engineered CAR NK cells can be an effective therapy against SARS-CoV-2 infection

May 27, 2022

PAI-1-TFT therapy shows promise for treating pleural empyema

May 26, 2022

Evusheld retains neutralization activity against SARS-CoV-2 Omicron BA.4 and BA.5 variants

May 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...